Tuberculosis: The success tale of less explored dormant Mycobacterium tuberculosis

A Verma, A Ghoshal, VP Dwivedi… - Frontiers in Cellular and …, 2022 - frontiersin.org
Mycobacterium tuberculosis (M. tb) is an intracellular pathogen that predominantly affects
the alveolar macrophages in the respiratory tract. Upon infection, the activation of TLR2 and …

Regulatory RNA in Mycobacterium tuberculosis, back to basics

S Schwenk, KB Arnvig - Pathogens and disease, 2018 - academic.oup.com
Since the turn of the millenium, RNA-based control of gene expression has added an extra
dimension to the central dogma of molecular biology. Still, the roles of Mycobacterium …

Cholesterol-dependent transcriptome remodeling reveals new insight into the contribution of cholesterol to Mycobacterium tuberculosis pathogenesis

J Pawełczyk, A Brzostek, A Minias, P Płociński… - Scientific reports, 2021 - nature.com
Mycobacterium tuberculosis (Mtb) is an obligate human pathogen that can adapt to the
various nutrients available during its life cycle. However, in the nutritionally stringent …

Premature termination of transcription is shaped by Rho and translated uORFS in Mycobacterium tuberculosis

A D'Halluin, P Polgar, T Kipkorir, Z Patel, T Cortes… - Iscience, 2023 - cell.com
Little is known about the decisions behind transcription elongation versus termination in the
human pathogen Mycobacterium tuberculosis (M. TB). By applying Term-seq to M. TB we …

The M. tuberculosis Rv1523 Methyltransferase Promotes Drug Resistance Through Methylation-Mediated Cell Wall Remodeling and Modulates Macrophages …

S Ali, A Ehtram, N Arora, P Manjunath, D Roy… - Frontiers in Cellular …, 2021 - frontiersin.org
The acquisition of antibiotics resistance is a major clinical challenge limiting the effective
prevention and treatment of the deadliest human infectious disease tuberculosis. The …

Synthesis and evaluation of antimycobacterial activity of riboflavin derivatives

B Harale, S Kidwai, D Ojha, M Singh… - Bioorganic & Medicinal …, 2021 - Elsevier
The riboflavin biosynthetic pathway is a promising target for the development of novel
antimycobacterial drugs given the lack of riboflavin transporter in M. tuberculosis. Herein, a …

[HTML][HTML] On a stake-out: Mycobacterial small RNA identification and regulation

S Taneja, T Dutta - Non-coding RNA research, 2019 - Elsevier
Persistence of mycobacteria in the hostile environment of human macrophage is pivotal for
its successful pathogenesis. Rapid adaptation to diverse stresses is the key aspect for their …

Characterization of the MurT/GatD complex in Mycobacterium tuberculosis towards validating a novel anti-tubercular drug target

A Maitra, S Nukala, R Dickman, LT Martin… - JAC-antimicrobial …, 2021 - academic.oup.com
Objectives Identification and validation of novel therapeutic targets is imperative to tackle the
rise of drug resistance in tuberculosis. An essential Mur ligase-like gene (Rv3712), expected …

Global-scale GWAS associates a subset of SNPs with animal-adapted variants in M. tuberculosis complex

EP Brenner, S Sreevatsan - BMC Medical Genomics, 2023 - Springer
Abstract Background While Mycobacterium tuberculosis complex (MTBC) variants are
clonal, variant tuberculosis is a human-adapted pathogen, and variant bovis infects many …

Expression of ribosomal protection protein RppA is regulated by a ribosome‐dependent ribo‐regulator and two mistranslation products

X Cai, Y Zhan, Z Cao, B Yan… - Environmental …, 2021 - Wiley Online Library
Gene expression is tightly controlled by transcription factors and RNA regulatory elements,
including trans‐acting small RNAs, cis‐regulatory riboswitches and ribosome‐dependent …